Calian Reports Results for the Fourth Quarter and Full Year 2025

(TSX:CGY), (All amounts in release are in Canadian dollars) OTTAWA, Ontario, Nov. 26, 2025 (GLOBE NEWSWIRE) — Calian(R) Group Ltd. (TSX:CGY), a mission critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, today released its results for the fourth quarter and fiscal year ended September 30, 2025. “Our fourth quarter […]

Fed Policy Shift Lifts Market Sentiment as Bitcoin Munari Enters Phase 2 at $0.22

HELSINKI, Nov. 26, 2025 (GLOBE NEWSWIRE) — Bitcoin Munari announced the opening of Phase 2 of its public presale at a fixed price of $0.22. The new round continues the project's structured distribution model, which progresses through predefined allocations and pricing ahead of BTCM's January 2026 release as a Solana SPL token. All tokens purchased

Aya Gold & Silver Reports Best Ever Mineral Intercept at Boumadine and Identifies New High-Grade Parallel Structure

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Nov. 26, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation“) is pleased to announce its strongest mineralized intercept to date, featuring a long, high-grade interval that results in a record metal factor, alongside the identification of a new high-grade parallel structure, both

USA Rare Earth Announces Preliminary Inclusion in the Russell 2000(R) Index

USA Rare Earth Announces Preliminary Inclusion in the Russell 2000(R) Index GlobeNewswire November 26, 2025 STILLWATER, Okla., Nov. 26, 2025 (GLOBE NEWSWIRE) — USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company), today announced that it has been included on the preliminary list for addition to the Russell 2000(R) Index as published in the

Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference

(NASDAQ:ARVN), NEW HAVEN, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Noah Berkowitz, M.D., Ph.D., Chief Medical Officer, and Andrew Saik, Chief Financial Officer, will participate in a fireside chat at the Piper Sandler

The Lovesac Company Announces Third Quarter Conference Call Date

(NasdaqGM:LOVE), STAMFORD, Conn., Nov. 26, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand, today announced that its third quarter financial results will be released before market open on Thursday, December 11, 2025. The Company will host a conference call at 8:30 a.m.

Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025

(NYSE MKT:PMI), TUCSON, Ariz., Nov. 26, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world's first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it will present in vitro data on the fully

Nasdaq Halts Charming Medical Limited

(NASDAQ:NDAQ),(NASDAQ:MCTA), NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — The Nasdaq Stock Market(R) (Nasdaq: NDAQ) announced that trading is halted in Charming Medical Limited (Nasdaq: MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November

OTC Markets Group Welcomes Erdene Resource Development Corp. to OTCQX

(Other OTC:OTCM),(OTC US:OTCM),(TSX:ERD),(Other OTC:ERDCF), NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Erdene Resource Development Corp. (TSX: ERD; OTCQX: ERDCF), a Canadian-based resource company, has qualified to trade on the OTCQX(R) Best Market. Erdene Resource Development

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

(NasdaqGM:TNGX), BOSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, is scheduled to participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 1:30pm ET. The live webcast will

Scroll to Top